Showing results (21-30 of 843) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|June 3, 2022
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate CancerNeil J Shah, Vaibhav G Patel, Xiaobo Zhong, et al.
JNCI Cancer Spectrum|June 14, 2022
Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal CancerShehara Mendis, Wei Hong, Sumitra Ananda, et al.
JNCI Cancer Spectrum|June 9, 2021
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site PerspectivesElizabeth J Siembida, Holli A Loomans-Kropp, Irene Tami-Maury, et al.
JNCI Cancer Spectrum|May 31, 2021
Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation StudyDiederik J Höppener, Boris Galjart, Pieter M H Nierop, et al.
JNCI Cancer Spectrum|January 1, 2021
Physical Activity for Oncological Patients in COVID-19 Era: No Time to RelaxAlice Avancini, Ilaria Trestini, Daniela Tregnago, et al.
JNCI Cancer Spectrum|February 4, 2022
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate BiopsyShusuke Akamatsu, Naoki Terada, Ryo Takata, et al.
JNCI Cancer Spectrum|January 31, 2022
Trends in Opioid Use Among Cancer Patients in the United States: 2013-2018Yingxi Chen, Susan Spillane, Meredith S Shiels, et al.
JNCI Cancer Spectrum|December 12, 2023
Progress in cancer control leads to a substantial number of cancer deaths avoided in CanadaMatthew T Warkentin, Yibing Ruan, Larry F Ellison, et al.
JNCI Cancer Spectrum|November 16, 2023
Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until deathGustav Stålhammar
JNCI Cancer Spectrum|August 29, 2023
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancerDawson Hill, Samuel R Kaufman, Mary K Oerline, et al.
Pageof 85